chr17-48543263-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002145.4(HOXB2):āc.876A>Cā(p.Glu292Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000162 in 1,608,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002145.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HOXB2 | NM_002145.4 | c.876A>C | p.Glu292Asp | missense_variant | 2/2 | ENST00000330070.6 | |
HOXB2 | XM_005257275.5 | c.549A>C | p.Glu183Asp | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HOXB2 | ENST00000330070.6 | c.876A>C | p.Glu292Asp | missense_variant | 2/2 | 1 | NM_002145.4 | P1 | |
HOXB2 | ENST00000571287.1 | n.521A>C | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151918Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000332 AC: 8AN: 240790Hom.: 0 AF XY: 0.0000456 AC XY: 6AN XY: 131494
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1457056Hom.: 0 Cov.: 33 AF XY: 0.0000221 AC XY: 16AN XY: 724974
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151918Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74188
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2022 | The c.876A>C (p.E292D) alteration is located in exon 2 (coding exon 2) of the HOXB2 gene. This alteration results from a A to C substitution at nucleotide position 876, causing the glutamic acid (E) at amino acid position 292 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at